Citadel Advisors’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-8,391
| Closed | -$762K | – | 9602 |
|
|
2018
Q1 | $661K | Buy |
+8,391
| New | +$619K | ﹤0.01% | 5421 |
|
|
2017
Q3 | – | Sell |
-8,507
| Closed | -$328K | – | 8394 |
|
|
2017
Q2 | $338K | Buy |
+8,507
| New | +$311K | ﹤0.01% | 5711 |
|
|
2017
Q1 | – | Sell |
-14,218
| Closed | -$355K | – | 8395 |
|
|
2016
Q4 | $252K | Buy |
+14,218
| New | +$306K | ﹤0.01% | 5928 |
|
|
2016
Q1 | – | Sell |
-5,145
| Closed | -$82.9K | – | 8690 |
|
|
2015
Q4 | $108K | Buy |
+5,145
| New | +$99.2K | ﹤0.01% | 6603 |
|
|
2015
Q2 | – | Sell |
-63,402
| Closed | -$3.05M | – | 9308 |
|
|
2015
Q1 | $3.05M | Buy |
63,402
+55,726
| +726% | +$2.53M | ﹤0.01% | 2568 |
|
|
2014
Q4 | $171K | Sell |
7,676
-8,184
| -52% | -$189K | ﹤0.01% | 6153 |
|
|
2014
Q3 | $301K | Buy |
+15,860
| New | +$378K | ﹤0.01% | 5257 |
|
|
2014
Q2 | – | Sell |
-1,135
| Closed | -$28.8K | – | 8520 |
|
|
2014
Q1 | $37K | Sell |
1,135
-26,222
| -96% | -$852K | ﹤0.01% | 6969 |
|
|
2013
Q4 | $651K | Sell |
27,357
-501,033
| -95% | -$14M | ﹤0.01% | 3706 |
|
|
2013
Q3 | $20.9M | Buy |
+528,390
| New | +$19.5M | 0.03% | 697 |
|
Citadel Advisors's FMI Position: Q2 2018 in Review
Citadel Advisors sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 8,391 shares — an estimated $762K sold.
Citadel Advisors first reported a position in FMI in Q3 2013 and held it in 10 quarters. The position peaked at $20.9M in Q3 2013. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.
- Citadel Advisors reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
- Citadel Advisors sold 8,391 Foundation Medicine, Inc. shares in Q2 2018, an estimated $762K.
- Citadel Advisors first reported a position in Foundation Medicine, Inc. in Q3 2013 and held it in 10 quarters.
- Citadel Advisors's Foundation Medicine, Inc. position peaked at $20.9M in Q3 2013.
- 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.
Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.